Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UPADACITINIB vs URSODIOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

UPADACITINIB vs URSODIOL: Safety Overview

Metric UPADACITINIB URSODIOL
Total FAERS Reports 65,656 3,624
Deaths Reported 2,406 539
Death Rate 3.7% 14.9%
Hospitalizations 15,931 1,257
Average Patient Age 57.4 yrs 44.3 yrs
% Female Patients 71.2% 61.7%
FDA Approval Date Apr 26, 2024 Aug 14, 2024
Manufacturer AbbVie Inc. Zydus Pharmaceuticals (USA) Inc.
Route ORAL ORAL
Marketing Status Prescription Discontinued